PTN and GTF2F1

Number of citations of the paper that reports this interaction (PubMedID 16169070)
820

Data Source:
BioGRID (two hybrid)
HPRD (two hybrid)

		PTN	GTF2F1
Description		pleiotrophin	general transcription factor IIF subunit 1
Image
GO Annotations	Cellular Component	Extracellular Region Basement Membrane Extracellular Space Endoplasmic Reticulum Plasma Membrane Cell Surface Neuromuscular Junction Protein-containing Complex Perinuclear Region Of Cytoplasm Presynapse Postsynapse	Nucleus Nucleoplasm Transcription Factor TFIID Complex Transcription Factor TFIIF Complex Cell Junction Protein-containing Complex Intracellular Membrane-bounded Organelle
	Molecular Function	Protein Phosphatase Inhibitor Activity Integrin Binding Protein Binding Growth Factor Activity Heparin Binding Protein Kinase Binding Chondroitin Sulfate Proteoglycan Binding Chondroitin Sulfate Binding Vascular Endothelial Growth Factor Binding Syndecan Binding Heparan Sulfate Binding	DNA Binding Transcription Coactivator Activity RNA Binding Protein Binding Transcription Factor Binding RNA Polymerase II General Transcription Initiation Factor Activity Phosphatase Activator Activity Protein Phosphatase Binding Protein Domain Specific Binding Promoter-specific Chromatin Binding
	Biological Process	Liver Development Leukocyte Chemotaxis Involved In Inflammatory Response Positive Regulation Of Leukocyte Chemotaxis Transmembrane Receptor Protein Tyrosine Phosphatase Signaling Pathway Integrin-mediated Signaling Pathway Nervous System Development Negative Regulation Of Neuroblast Proliferation Heart Development Learning Memory Positive Regulation Of Cell Proliferation Regulation Of Cell Shape Regulation Of Endothelial Cell Migration Positive Regulation Of Cell-substrate Adhesion Positive Regulation Of Neuron Projection Development Response To Auditory Stimulus Response To Activity Negative Regulation Of Angiogenesis Spinal Cord Development Cerebellum Development Thalamus Development Bone Mineralization Lung Development Negative Regulation Of Cell Migration Positive Regulation Of Bone Mineralization Dendrite Regeneration Regulation Of Myelination Response To Estradiol Negative Regulation Of Phosphoprotein Phosphatase Activity Response To Progesterone Cellular Response To UV Cellular Response To Platelet-derived Growth Factor Stimulus Tissue Regeneration Positive Regulation Of Apoptotic Process Receptor Clustering Ossification Involved In Bone Remodeling Estrous Cycle Endothelial Cell Differentiation Positive Regulation Of Ossification Negative Regulation Of Membrane Potential Decidualization Regulation Of Synaptic Plasticity Oogenesis Positive Regulation Of Axon Regeneration Positive Regulation Of Oligodendrocyte Differentiation Negative Regulation Of Epithelial Cell Proliferation Positive Regulation Of Cell Division Retinal Rod Cell Differentiation Negative Regulation Of Glial Cell Proliferation Long-term Synaptic Potentiation Cellular Response To Vitamin D Cellular Response To Hypoxia Negative Regulation Of Mesenchymal Cell Proliferation Dendrite Arborization Positive Regulation Of Dendrite Development Negative Regulation Of Long-term Synaptic Potentiation Regulation Of Hemopoiesis Response To Kainic Acid Rod Bipolar Cell Differentiation Response To Ciliary Neurotrophic Factor Positive Regulation Of Skeletal Muscle Acetylcholine-gated Channel Clustering Negative Regulation Of Neuromuscular Junction Development Response To Nerve Growth Factor Regulation Of Stem Cell Population Maintenance Positive Regulation Of Hepatocyte Proliferation Positive Regulation Of Stem Cell Differentiation	MRNA Splicing, Via Spliceosome Transcription By RNA Polymerase II Transcription Initiation From RNA Polymerase II Promoter Transcription Elongation From RNA Polymerase II Promoter 7-methylguanosine MRNA Capping Fibroblast Growth Factor Receptor Signaling Pathway Response To Virus RNA Metabolic Process Negative Regulation Of Protein Binding Positive Regulation Of Transcription Elongation From RNA Polymerase II Promoter SnRNA Transcription By RNA Polymerase II Positive Regulation Of Catalytic Activity Positive Regulation Of Transcription By RNA Polymerase II Positive Regulation Of Viral Transcription
Pathways			Formation of RNA Pol II elongation complex Formation of the Early Elongation Complex Formation of HIV elongation complex in the absence of HIV Tat Formation of the HIV-1 Early Elongation Complex RNA Pol II CTD phosphorylation and interaction with CE during HIV infection HIV Transcription Initiation RNA Polymerase II HIV Promoter Escape Transcription of the HIV genome Formation of HIV-1 elongation complex containing HIV-1 Tat Formation of HIV-1 elongation complex containing HIV-1 Tat Pausing and recovery of Tat-mediated HIV elongation Abortive elongation of HIV-1 transcript in the absence of Tat Tat-mediated HIV elongation arrest and recovery Tat-mediated elongation of the HIV-1 transcript HIV elongation arrest and recovery Pausing and recovery of HIV elongation Viral Messenger RNA Synthesis RNA Polymerase II Pre-transcription Events TP53 Regulates Transcription of DNA Repair Genes FGFR2 alternative splicing RNA polymerase II transcribes snRNA genes RNA polymerase II transcribes snRNA genes mRNA Capping mRNA Splicing - Major Pathway mRNA Splicing - Minor Pathway Processing of Capped Intron-Containing Pre-mRNA RNA Polymerase II Promoter Escape RNA Polymerase II Transcription Pre-Initiation And Promoter Opening RNA Polymerase II Transcription Initiation RNA Polymerase II Transcription Elongation RNA Polymerase II Transcription Initiation And Promoter Clearance RNA Pol II CTD phosphorylation and interaction with CE Signaling by FGFR2 IIIa TM Estrogen-dependent gene expression
Drugs
Diseases
GWAS		Aluminium levels ( 26025379) anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028) Blood protein levels ( 30072576 29875488) Metabolite levels ( 23823483) Neurociticism ( 29500382) Paclitaxel disposition in epithelial ovarian cancer ( 29367611) Schizophrenia ( 25056061 29483656)
Interacting Genes		97 interacting genes: ACTB ALK APOBEC3G ARIH2 ARL15 ATP5F1C ATRX BAG6 BARD1 BCCIP BCL2L1 BLOC1S1 BMI1 BTBD2 C11orf58 C7orf25 CAAP1 CACNB4 CAPZB CDH10 CDK5RAP2 CGA CHD3 COX6C CRCT1 CRELD1 CSTA CYP2E1 DNAJB11 DUSP12 EIF3F EVA1A FEZ1 FTL GADD45A GADD45G GIPC2 GLYAT GPD1 GPRASP2 GSDME GSK3B GSTP1 GTF2F1 HGH1 HSPBAP1 ITSN2 KPNB1 LAMA4 LUC7L2 MAD2L1BP MKKS MLLT3 MRPL44 MYCBP NAP1L5 NCAN NEK6 NUDT21 P4HB PFDN1 PIAS4 PLXNB2 PMF1 PPP2CA PSMB10 PSMD11 PSMD2 PTPRS PTPRZ1 RACK1 RBM23 RIT1 RPLP1 SAT1 SDC1 SDC3 SGSM2 SGTA SLC25A36 SNCAIP SPIN1 SSR1 STC2 SUPT7L TAC3 TAF1D TBRG4 TOMM20 TP53BP2 TSC22D1 TXNDC9 UBQLN1 UBQLN4 UTP3 WASHC3 WFDC2	31 interacting genes: ABL1 AHR AR ARNT ATF7IP CCNT1 CDK9 CSNK2A1 CTDP1 CTDSP1 DAPK1 FEZ1 FOS GTF2A1 GTF2B GTF2E2 GTF2F2 GTF2H4 JUN MAGEC1 MSX2 MYC PARP1 POLR2A PSMC2 PTN SRF TAF1 TAF11 TBP TRIM27
Entrez ID		5764	2962
HPRD ID		01199	01803
Ensembl ID		ENSG00000105894	ENSG00000125651
Uniprot IDs		A0A024R778 P21246	P35269
PDB IDs		2N6F	1F3U 1I27 1J2X 1NHA 1ONV 2K7L 5IY6 5IY7 5IY8 5IY9 5IYA 5IYB 5IYC 5IYD 6O9L
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?